Drug Trial Radar · NCT01302119
Efficacy and Safety of AN2690 Topical Solution to Treat Onychomycosis of the Toenail
Last checked: Nov 19, 2026Latest source record: Apr 3, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
604
Actual
Start
Feb 2011
Primary completion
Dec 31, 2012
Study completion Feb 20, 2013
Sponsor
- Lead sponsor
- PfizerPfizer (PFE)
- Sponsor type
- Industry
- First posted
- Feb 23, 2011
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to determine whether AN2690 topical solution is a safe and effective treatment for onychomycosis of the toenail.
Conditions
- Onychomycosis of Toenails
Interventions
AN2690 Topical Solution, 5%Drug
AN2690 Topical Solution, 5%, applied once daily for 48 weeks
Solution VehicleDrug
AN2690 Topical Solution, Vehicle, applied once daily for 48 weeks
Primary outcomes
What the sponsor says the trial is designed to measure.
- Complete Cure (Completely Clear Nail and Negative Mycology) of Target Great Toenail at Week 52Time frame: Week 52
Locations
32 sites in 2 countries. Site status is shown where the registry gives one.
Investigational Site
Phoenix, Arizona
Investigational Site
Novato, California
Investigational Site
Oceanside, California
Investigational Site
San Diego, California
Investigational Site
San Francisco, California
Investigational Site
Santa Rosa, California
Investigational Site
Miami, Florida
Investigational Site
Miami, Florida
Investigational Site
Nampa, Idaho
Investigational Site
Evansville, Indiana
Investigational Site
Ann Arbor, Michigan
Investigational Site
St Louis, Missouri
Investigational Site
Verona, New Jersey
Investigational Site
Albuquerque, New Mexico
Investigational Site
High Point, North Carolina
Investigational Site
Raleigh, North Carolina
Investigational Site
Columbus, Ohio
Investigational Site
Portland, Oregon
Investigational Site
Philadelphia, Pennsylvania
Investigational Site
Greer, South Carolina
Investigational Site
Knoxville, Tennessee
Investigational Site
Dallas, Texas
Investigational Site
San Antonio, Texas
Investigational Site
Salt Lake City, Utah
Investigational Site
Harrisonburg, Virginia
Investigational Site
Norfolk, Virginia
Investigational Site
Québec, Canada
Investigational Site
Barrie, Ontario, Canada
Investigational Site
Markham, Ontario, Canada
Investigational Site
North Bay, Ontario, Canada
Investigational Site
Boucherville, Quebec, Canada
Investigational Site
Montreal, Quebec, Canada
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.